Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
Analytical Cellular Pathology · 20.03.2020 · 2020 · 1-15
DOI: 10.1155/2020/3153891 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Analytical Cellular Pathology, erschienen am 20.03.2020. Verfasst von Carl Randall Harrell und 9 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Processing Plant, LLC, 34176 US Highway 19 N, Palm Harbor, Florida, USA. Hauptthemen laut MEDLINE: Exosomes. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medical Sciences University of Kragujevac, Serbian Ministry of Science.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs), due to their potential for differentiation into alveolar epithelial cells and their immunosuppressive characteristics, are considered a new therapeutic agent in cell-based therapy of inflammatory lung disorders, including chronic obstructive pulmonary disease (COPD). Since most of the MSC-mediated beneficent effects were the consequence of their paracrine action, herewith, we investigated the effects of a newly designed MSC-derived product “Exosome-derived Multiple Allogeneic Protein Paracrine Signaling (Exo-d-MAPPS)” in the attenuation of chronic airway inflammation by using an animal model of COPD (induced by chronic exposure to cigarette smoke (CS)) and clinical data obtained from Exo-d-MAPPS-treated COPD patients. Exo-d-MAPPS contains a high concentration of immunomodulatory factors which are capable of attenuating chronic airway inflammation, including soluble TNF receptors I and II, IL-1 receptor antagonist, and soluble receptor for advanced glycation end products. Accordingly, Exo-d-MAPPS significantly improved respiratory function, downregulated serum levels of inflammatory cytokines (TNF- α , IL-1 β , IL-12, and IFN- γ ), increased serum concentration of immunosuppressive IL-10, and attenuated chronic airway inflammation in CS-exposed mice. The cellular makeup of the lungs revealed that Exo-d-MAPPS treatment attenuated the production of inflammatory cytokines in lung-infiltrated macrophages, neutrophils, and natural killer and natural killer T cells and alleviated the antigen-presenting properties of lung-infiltrated macrophages and dendritic cells (DCs). Additionally, Exo-d-MAPPS promoted the expansion of immunosuppressive IL-10-producing alternatively activated macrophages, regulatory DCs, and CD4+FoxP3+T regulatory cells in inflamed lungs which resulted in the attenuation of chronic airway inflammation. In a similar manner, as it was observed in an animal model, Exo-d-MAPPS treatment significantly improved the pulmonary status and quality of life of COPD patients. Importantly, Exo-d-MAPPS was well tolerated since none of the 30 COPD patients reported any adverse effects after Exo-d-MAPPS administration. In summing up, we believe that Exo-d-MAPPS could be considered a potentially new therapeutic agent in the treatment of chronic inflammatory lung diseases whose efficacy should be further explored in large clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Regenerative Processing Plant, LLC, 34176 US Highway 19 N, Palm Harbor, Florida, USA.
- Center for Molecular Medicine and Stem Cell Research, Department for Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozar Markovic Street, Kragujevac, Serbia.
- Emory University School of Medicine, 648 Pierce Dr. NE, Atlanta, GA, USA.
- Atlanta VA Medical Center, 1670 Clairmont Rd., Decatur/Atlanta, GA, USA.
- Institute of Anatomy, University of Bern, 2 Baltzerstrasse, Switzerland.
ORCID-Profile: Bojana Simovic Markovic, Vladislav Volarevic
Förderung
- Faculty of Medical Sciences University of Kragujevac
- Serbian Ministry of Science
Zitieren
APA
Harrell, C. R., Miloradovic, D., Sadikot, R., Fellabaum, C., Markovic, B. S., Miloradovic, D., Acovic, A., Djonov, V., Arsenijevic, N., & Volarevic, V. (2020). Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation. Analytical Cellular Pathology, 2020, 1-15. https://doi.org/10.1155/2020/3153891
Vancouver
Harrell CR, Miloradovic D, Sadikot R, Fellabaum C, Markovic BS, Miloradovic D, et al. Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation. Analytical Cellular Pathology. 2020;2020:1-15. doi:10.1155/2020/3153891
BibTeX
@article{Harrell2020,
author = {Harrell, Carl Randall and Miloradovic, Dragica and Sadikot, Ruxana and Fellabaum, Crissy and Markovic, Bojana Simovic and Miloradovic, Dragana and Acovic, Aleksandar and Djonov, Valentin and Arsenijevic, Nebojsa and Volarevic, Vladislav},
title = {Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation},
journal = {Analytical Cellular Pathology},
year = {2020},
volume = {2020},
pages = {1--15},
doi = {10.1155/2020/3153891}
}
EUVIMED